- Home
- LEGT vs BLDE Comparison
LEGT vs BLDE Comparison
Compare LEGT & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGT
- BLDE
- Stock Information
- Founded
- LEGT 2023
- BLDE 2014
- Country
- LEGT United States
- BLDE United States
- Employees
- LEGT N/A
- BLDE N/A
- Industry
- LEGT
- BLDE Aerospace
- Sector
- LEGT
- BLDE Consumer Discretionary
- Exchange
- LEGT Nasdaq
- BLDE Nasdaq
- Market Cap
- LEGT 265.5M
- BLDE 276.7M
- IPO Year
- LEGT 2024
- BLDE N/A
- Fundamental
- Price
- LEGT $10.30
- BLDE $3.95
- Analyst Decision
- LEGT
- BLDE Buy
- Analyst Count
- LEGT 0
- BLDE 1
- Target Price
- LEGT N/A
- BLDE $6.00
- AVG Volume (30 Days)
- LEGT 33.4K
- BLDE 1.6M
- Earning Date
- LEGT 01-01-0001
- BLDE 11-12-2024
- Dividend Yield
- LEGT N/A
- BLDE N/A
- EPS Growth
- LEGT N/A
- BLDE N/A
- EPS
- LEGT N/A
- BLDE N/A
- Revenue
- LEGT N/A
- BLDE $241,814,000.00
- Revenue This Year
- LEGT N/A
- BLDE $11.34
- Revenue Next Year
- LEGT N/A
- BLDE $5.73
- P/E Ratio
- LEGT N/A
- BLDE N/A
- Revenue Growth
- LEGT N/A
- BLDE 12.04
- 52 Week Low
- LEGT $10.00
- BLDE $2.45
- 52 Week High
- LEGT $10.47
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- LEGT N/A
- BLDE 47.19
- Support Level
- LEGT N/A
- BLDE $3.95
- Resistance Level
- LEGT N/A
- BLDE $4.45
- Average True Range (ATR)
- LEGT 0.00
- BLDE 0.37
- MACD
- LEGT 0.00
- BLDE -0.08
- Stochastic Oscillator
- LEGT 0.00
- BLDE 11.45
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.